Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 143,201 shares.
Evofem Biosciences Stock Up 8.3%
The stock has a market cap of $1.03 million, a price-to-earnings ratio of -0.01 and a beta of -1.00. The company has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.01.
About Evofem Biosciences
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Stories
- Five stocks we like better than Evofem Biosciences
- What is the S&P 500 and How It is Distinct from Other Indexes
- Walmart Stock Alert: Big Price Move Expected Soon
- What Do S&P 500 Stocks Tell Investors About the Market?
- An Acquisition Just Made Dick’s the Most Exciting Stock in Retail
- Health Care Stocks Explained: Why You Might Want to Invest
- Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
